Sarah D. E. StaplesAssociate K&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmail615-780-6756 Professional Biography Sarah Staples is an associate in the firm’s Nashville office and is a member of the Health Care and FDA practice group. More Legal and Business Bylines From Sarah D. E. Staples Corporate Practice of Medicine Doctrine: Part 1 [Podcast] - (Posted On Tuesday, April 09, 2024) DEA Temporarily Extends COVID-19 Flexibilities for Controlled Substance Prescriptions via Telemedicine While Evaluating Permanent Rule Changes - (Posted On Monday, May 15, 2023) Consolidated Appropriations Act of 2023 Extends Telehealth Waivers - (Posted On Monday, February 06, 2023) CMS's Proposal for New Remote Therapeutic Monitoring Codes Under the 2022 Medicare Physician Fee Schedule [PODCAST] - (Posted On Thursday, August 19, 2021) Connect for Health Act of 2021 Reintroduced - (Posted On Tuesday, June 22, 2021) Current Legal Analysis USCIS Announces Initial FY 2026 H-1B Cap Selection: What Employers Need to Do Next by: Jessica K. Lang SEC Provides Further Clarity in Rule 506(c) Offerings by: Daniel I. DeWolf , Samuel Asher Effron FedRAMP 20x – Major Overhaul Announced to Streamline the Security Authorization Process for Government Cloud Offerings by: Townsend L. Bourne , Daniel J. Alvarado USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program by: Lynn L. Bergeson , Carla N. Hutton Immigration Enforcement and Healthcare Facilities: Key Considerations for Providers by: Lotan Barbaresso , Amy J. Dilcher The Third Time’s A Charm: Colorado Adds Nuclear Energy as a Clean Energy Resource by: Thomas J. Dougherty SEC Policy Shift and Recent Corp Fin Updates – Part 1 by: Julie F. Rizzo , Linsey N. Taulbee Corporate Transparency Act Update: Drastic Reduction in Scope of BOI Reporting in March 21, 2025 FinCEN Guidance by: Jonathan F.X. O’Brien USPTO Implements Bifurcated Review Process for Patent Petitions Under New Policy by: Preston H. Heard , Kyle W. Kellar Trump Administration Efforts to Eliminate Cartels Pose Heightened Risk for Financial Institutions by: Seth D. DuCharme GLP-1 Receptor Agonists: Drug Litigation Overview and Trends by: Liane M. Peterson Supreme Court Declines Review of “Relational Analysis” for Determining Administrative Exemption by: Michael Reed Kentucky Legislature Ends Judicial Deference To State Agencies by: Stephen P. Kranz , Michael J. Hilkin VHA and DLA Enter Into Another Interagency Agreement: Déjà Vu All Over Again? by: Merle M. DeLancey Jr. When Is Conduct ‘Primarily and Substantially’ in Massachusetts Under Chapter 93A? by: David G. Thomas , Angela C. Bunnell Upcoming Events Apr 30 2025 Workplace Horizons 2025 Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 7 2025 Understanding the Basics of a Class Action Print
